The diversification of analytical
tools for diagnosis of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is imperative
for effective virus surveillance and transmission control worldwide.
Development of robust methods for rapid, simple isolation of viral
RNA permits more expedient pathogen detection by downstream real-time
reverse transcriptase polymerase chain reaction (real-time RT-PCR)
to minimize stalled containment and enhance treatment efforts. Here,
we describe an automatable rotationally driven microfluidic platform
for enrichment and enzymatic extraction of SARS-CoV-2 RNA from multiple
sample types. The multiplexed, enclosed microfluidic centrifugal device
(μCD) is capable of preparing amplification-ready RNA from up
to six samples in under 15 min, minimizing user intervention and limiting
analyst exposure to pathogens. Sample enrichment leverages Nanotrap
Magnetic Virus Particles to isolate intact SARS-CoV-2 virions from
nasopharyngeal and/or saliva samples, enabling the removal of complex
matrices that inhibit downstream RNA amplification and detection.
Subsequently, viral capsids are lysed using an enzymatic lysis cocktail
for release of pathogenic nucleic acids into a PCR-compatible buffer,
obviating the need for downstream purification. Early in-tube assay
characterization demonstrated comparable performance between our technique
and a “gold-standard” commercial RNA extraction and
purification kit. RNA obtained using the fully integrated μCDs
permitted reliable SARS-CoV-2 detection by real-time RT-PCR. Notably,
we successfully analyzed full-process controls, positive clinical
nasopharyngeal swabs suspended in viral transport media, and spiked
saliva samples, showcasing the method’s broad applicability
with multiple sample matrices commonly encountered in clinical diagnostics.